This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Todaro-Luck, F Articles by Kaufman, L Search for Related Content PubMed PubMed Citation Articles by Todaro-Luck, F Articles by Kaufman, L

 Previous Article  |  Next Article 

Infect Immun. 1989 December; 57(12): 3882-3887

Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.

Istituto di Microbiologia, Facolta di Medicina, Universita di Messina, Italy.

ABSTRACT

Mice were immunized with Cryptococcus neoformans serotype A capsular glucuronoxylomannan (GXM) conjugated to bovine serum albumin-adipic dihydrazide. Two splenocyte fusions yielded two monoclonal antibodies (MAbs) that were highly reactive in dot enzyme immunoassay, immunofluorescence, and sandwich enzyme immunoassay. The first MAb, BD-1 [immunoglobulin G1 (kappa) [IgG1(kappa)]], was GXM-A and GXM-D specific, whereas the second MAb, BA-4 (IgM), reacted with GXM-A and GXM-B. A third MAb, CD-6 [IgG1(kappa)], originated from mice immunized with O-deacetylated GXM-C-bovine serum albumin and reacted with GXMs of all four serotypes. Two of the MAbs (CD-6 and BD-1) were further characterized with chemically modified GXMs. Removal of glucuronosyl residues completely inhibited the binding of both MAbs, implicating (1----2)-beta-glucuronic acid as a key component of the epitope. Removal of (1----2)-beta-xylosyl residues decreased reactivity to an intermediate extent. O deacetylation led to a measurable decrease but had the least inhibitory effect of the three GXM derivatives tested. The combining site for these two MAbs appears to be a complex antigenic determinant involving more than one glycosidic residue.

This article has been cited by other articles:

• Cook, E., Wang, X., Robiou, N., Fries, B. C. (2007). Measurement of Staphylococcal Enterotoxin B in Serum and Culture Supernatant with a Capture Enzyme-Linked Immunosorbent Assay. CVI 14: 1094-1101 [Abstract] [Full Text]  
• Martinez, L. R., Casadevall, A. (2005). Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective Efficacy. Infect. Immun. 73: 6350-6362 [Abstract] [Full Text]  
• Feldmesser, M., Rivera, J., Kress, Y., Kozel, T. R., Casadevall, A. (2000). Antibody Interactions with the Capsule of Cryptococcus neoformans. Infect. Immun. 68: 3642-3650 [Abstract] [Full Text]  
• Nussbaum, G., Anandasabapathy, S., Mukherjee, J., Fan, M., Casadevall, A., Scharff, M. D. (1999). Molecular and Idiotypic Analyses of the Antibody Response to Cryptococcus neoformans Glucuronoxylomannan-Protein Conjugate Vaccine in Autoimmune and Nonautoimmune Mice. Infect. Immun. 67: 4469-4476 [Abstract] [Full Text]  
• Cleare, W., Cherniak, R., Casadevall, A. (1999). In Vitro and In Vivo Stability a Cryptococcus neoformans Glucuronoxylomannan Epitope That Elicits Protective Antibodies. Infect. Immun. 67: 3096-3107 [Abstract] [Full Text]  
• Cleare, W., Casadevall, A. (1998). The Different Binding Patterns of Two Immunoglobulin M Monoclonal Antibodies to Cryptococcus neoformans Serotype A and D Strains Correlate with Serotype Classification and Differences in Functional Assays. CVI 5: 125-129 [Abstract] [Full Text]